Antipsychotic polypharmacy in psychiatric practice: is it really doomed?

Abstract

Get full access to this article

View all access options for this article.

References

Patrick

Levin

Schleifer

. Antipsychotic polypharmacy: Is there evidence for its use? J Psychiatr Pract 2005; 11: 248–257.

Essock

Schooler

Stroup

. Effectiveness of switching from antipsychotic polypharmacy to monotherapy. Am J Psychiatry 2011; 168: 702–708.

Correll

Gallego

. Antipsychotic polypharmacy: A comprehensive evaluation of relevant correlates of a long-standing clinical practice. Psychiatr Clin North Am 2012; 35: 661–681.

Goff

Dixon

. Antipsychotic polypharmacy: Are two ever better than one? Am J Psychiatry 2011; 168: 7.

Tiihonen

Suokas

Suvisaari

. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry 2012; 69: 476–483.

Baandrup

Gasse

Jensen

. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: A population-based nested case-control study. J Clin Psychiatry 2010; 71: 103–108.